R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 구조식 이미지
카스 번호:
1011465-29-4
상품명:
R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
동의어(영문):
R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d;(R)-3,3'-Bis(9-anthracenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2-naphthyl HydrogenPhosphate;(R)-3,3'-Bis(9-anthracenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2-naphthyl Hydrogen Phosphate;R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR) -2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4- hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bR)-;(11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e.;(11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95% (99% ee)
CBNumber:
CB82676290
분자식:
C48H37O4P
포뮬러 무게:
708.78
MOL 파일:
1011465-29-4.mol

R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 속성

녹는점
244-246 °C (decomp)
밀도
1.40±0.1 g/cm3(Predicted)
산도 계수 (pKa)
1.17±0.20(Predicted)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H315 피부에 자극을 일으킴 피부부식성 또는 자극성물질 구분 2 경고 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
예방조치문구:
P264 취급 후에는 손을 철저히 씻으시오.
P264 취급 후에는 손을 철저히 씻으시오.
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
P302+P352 피부에 묻으면 다량의 물로 씻으시오.
P332+P313 피부 자극이 생기면 의학적인 조치· 조언을 구하시오.

R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin C화학적 특성, 용도, 생산

R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 준비 용품 및 원자재

원자재

준비 용품


R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 공급 업체

글로벌( 23)공급 업체
공급자 전화 이메일 국가 제품 수 이점
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
Daicel Chiral Technologies (China)CO.,LTD 021-50460086-9 15921403865
han_yajun@dctc.daicel.com China 6818 65
Tianjin Derchemist Science & Technology Co., Ltd. 22-58627059 13920586291
zdcomcon@126.com China 2918 50
Bide Pharmatech Ltd. 400-1647117 15221909166
product02@bidepharm.com China 41438 60
Shanghai Chiral bio-compound co., Ltd. 021-5068 3667/17749785980/1029026415; 17749785980
1029026415@qq.com China 2790 58
LaaJoo 021-60702684 18516024827
huang.jiayi@sinocompound.com China 2654 58
Greenherbs Science and Technology Development Co., Ltd. 010-61136123
pub02@greenherbs.com.cn China 4049 58
Shanghai Anyinuo Biomedical Technology Co., Ltd. 021-88888888
420970979@qq.com China 2806 58
Shanghai Suifu Chemical Technology CO.,LTD. +86-021-33738187 +86-17736114707
suifuchemical@163.com China 585 58

R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 관련 검색:

(11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide (11bS)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (R)-4-oxide-2,6-bis[4-(1,1-dimethylethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate (S)-3,3'-Bis[3,5-bis(trifluoromethyl)phenyl]-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e. (S)-4-oxide-2,6-bisbis([1,1':3',1''-terphenyl]-5'-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-diphenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate (S)-5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthyl phosphate (11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (S)-3,3'-Bis(2-naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin S- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis((3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate R- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
Copyright 2019 © ChemicalBook. All rights reserved